Skip to main content
AURORA CANNABIS INC logo

AURORA CANNABIS INC — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8843 LEI · 549300F6VHCLKCUWDT34 US Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2021-01-28 Regulatory Filings
Country CA Canada
Listing US ACB

About AURORA CANNABIS INC

https://www.auroramj.com/

Aurora Cannabis Inc. is a global company engaged in the production, distribution, and sale of cannabis and cannabis-derivative products. The company serves both the medical and adult-use recreational markets. Its product portfolio includes a range of items such as dried cannabis and cannabis oils. Aurora focuses on establishing a leadership position in the global medical cannabis sector, with an emphasis on patient care and education, and is dedicated to providing products to improve consumer well-being.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules under the Securities Exchange Act of 1934. The document is short (1760 characters) and primarily serves as a cover report referencing a news release exhibit dated January 28, 2021. It does not contain detailed financial statements or substantive financial data itself, nor does it present a full annual or interim report. It is a regulatory filing to inform the SEC and investors of a news release, thus fitting the category of Regulatory Filings (RNS).
2021-01-28 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules under the Securities Exchange Act of 1934. It includes a news release dated January 27, 2021, but the document itself is short (1760 characters) and primarily serves as a regulatory filing to report information to the SEC. There is no substantive financial data or detailed report content such as an annual or quarterly report. The document is not an earnings release, management report, or any other detailed financial or governance report. It is a regulatory filing to comply with SEC requirements for foreign issuers. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-01-28 English
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Aurora Cannabis Inc., with the SEC. It includes a Warrant Indenture as an exhibit, which relates to a financing or capital structure arrangement. The document is short (1674 characters) and primarily serves as a filing to report this event rather than a full financial report. Form 6-K filings typically cover material events for foreign issuers, often including capital or financing updates. Given the presence of a Warrant Indenture and the nature of the filing, the most appropriate classification is Capital/Financing Update (CAP).
2021-01-26 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to SEC rules under the Securities Exchange Act of 1934. It includes a news release dated January 26, 2021, but the document itself is short (1760 characters) and primarily serves as a regulatory filing to report current information. There is no detailed financial data, management discussion, or full report content. According to the rules, Form 6-K filings are considered Regulatory Filings (RNS) as they are periodic reports for foreign issuers and do not constitute full annual or interim reports. The document is not an announcement of a report publication but the report itself, which fits the Regulatory Filings category.
2021-01-26 English
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by Aurora Cannabis Inc., which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content includes an underwriting agreement exhibit related to financing activities. The document length is short (1730 characters) and it primarily announces the filing of an underwriting agreement, which is related to capital raising or financing. There are no detailed financial statements or comprehensive financial data presented, so it is not an Annual Report (10-K) or Interim Report (IR). The presence of an underwriting agreement indicates a financing update. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2021-01-26 English
SUPPL
Capital/Financing Update Classification · 95% confidence The document is a Prospectus Supplement filed pursuant to Form F-10, related to a securities offering by Aurora Cannabis Inc. It discusses the issuance of common shares and warrants, listing on stock exchanges, and regulatory compliance with Canadian and U.S. securities authorities. The text includes detailed offering terms, risk factors, and legal notices typical of a prospectus supplement. It is not a financial report, earnings release, or management discussion, but a capital markets document related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual supplement, not just an announcement of a report. Hence, the classification is CAP with high confidence.
2021-01-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.